GSK's China Venture Enters Health Products Sector
This article was originally published in PharmAsia News
Executive Summary
Tianjin Smith Kline & French Lab, which has been focusing on the OTC business for 21 years in China, marked its entry into the country's healthcare product business last month by launching parent company GlaxoSmithKline's Sensodyne toothpaste. GSK's oral health and health food sectors contribute 27 percent each to its total revenue. As the pharmaceutical giant's China joint venture, TSKF will fully operate the local consumer health business and introduce other items including health food in the near feature. TSKF notes that with the domestic market emerging, the time is right to promote such products. However, it will still concentrate on the OTC business during the next five years even as it increases investments in other sectors. (Click here for more - Chinese Language)